Researchers are testing whether a combination of two long-acting HIV antibodies and a low dose of the cancer immunotherapy nivolumab can help people with HIV control the virus without antiretroviral therapy. The trial enrolls 90 adults whose HIV is already well suppressed on stan…
Phase 2 • Sponsor: Ole Schmeltz Søgaard • Aim: Cure
Last updated Sep 17, 2026 00:00 UTC